🔔 After the Bell

Index Price Change
S&P 5006,506.48-1.51%
Dow Jones45,577.47-0.96%
Nasdaq21,647.61-2.01%
10Y Treasury4.39%+0.11%
U.S. Dollar99.57+0.13%
Bitcoin$70,187+0.39%

🎯 Session Review

Wall Street wrapped up the week with a thud on Friday, as all three major indexes tumbled into the close. The S&P 500 dropped 100 points to 6,506.48, falling 1.51%, while the Nasdaq bore the brunt of selling pressure with a 2.01% decline to 21,647.61. The Dow held up relatively better, shedding just 0.96% to close at 45,577.47.

The selloff came as Treasury yields marched higher across the curve, with the 10-year note jumping 11 basis points to 4.39%. That move in rates put particular pressure on growth stocks and high-valuation tech names that dominated the trending losers list. The dollar strengthened to 99.57 as investors rotated away from risk assets, though Bitcoin managed a modest 0.39% gain to $70,187.

Trading volume picked up into the close as portfolio managers squared positions heading into the weekend. The broad-based nature of the decline, with tech, industrials, and energy all participating in the downdraft, suggested macro concerns rather than sector-specific issues were driving the action.

📊 Today's Market Movers

▲ Gainers
PL +25.59%
PSNYW +20.14%
YSS +19.29%
SEDG +13.21%
VG +10.29%
▼ Losers
SMCI -33.32%
AAOI -14.11%
VICR -13.46%
VST -12.52%
FLOC -11.04%

🚀 Key Catalysts

Healthcare made headlines on both sides of the regulatory ledger. Bristol Myers Squibb (BMY) notched a win with FDA approval for its Hodgkin's lymphoma combination treatment for adults and adolescents 12 and older with previously untreated Stage III or IV disease. That's a significant market expansion for the drug giant. But the FDA also brought the hammer down on Parkinson's medications, warning AbbVie (ABBV), Amneal (AMRX), and Novartis (NVS) about seizure risks and requesting label updates.

In the M&A space, Prestige Consumer Healthcare (PBH) went shopping, dropping $1.045 billion to acquire Breathe Right nasal strips and other brands from privately held Foundation Consumer Healthcare. Meanwhile, IAG (ICAGY), British Airways' parent company, reportedly plans to abandon its bid for Portugal's TAP airline according to Bloomberg sources.

Content took center stage with Netflix (NFLX) and Warner Music Group (WMG) inking a multi-year partnership for exclusive documentary series and films exploring the lives and legacies of Warner's legendary artists. On the other end of the media spectrum, CBS News parent Paramount Global (PSKY) is cutting 6% of staff as new Editor-in-Chief Bari Weiss attempts to revitalize the network and boost ratings.
Sponsored Content

Wall St Legend: AGI Arrives Q1 2026. The Power Grab Started Months Ago.

While retail buys Nvidia at all-time highs, institutions position into something else. Why? AI needs POWER. Louis Navellier, who spent 46 yrs Wall St. and called Nvidia at $1, reveals that his grading system shows where the money is REALLY flowing. Companies you've never heard of. Stocks the media never covers. Before Stage 3 begins...

🎭 Investor Mood

Investor Pulse: Yield Shock
The market's mood soured as rising yields reminded investors that the bond market still has a vote. When the 10-year Treasury jumps 11 basis points in a single session, it fundamentally changes the discount rate equation for equities, particularly growth stocks trading at elevated multiples. That math problem hit tech especially hard, with the Nasdaq's 2% drop reflecting renewed valuation anxiety.

Geopolitical tensions around U.S.-China relations bubbled up again as Tim Cook's China visit highlighted Apple's (AAPL) uncomfortable dependence on the region. The company just cut its App Store commission from 30% to 25% under pressure from Beijing regulators, but the official Communist Party newspaper is demanding further reductions. That kind of regulatory squeeze on a $3 trillion company shows how vulnerable even the biggest tech giants remain to government pressure.

Trending stocks told the story of sector rotation and volatility. Super Micro Computer (SMCI) cratered 10.26 points, ASML (ASML) got hammered down 49.14, and XPeng (XPEV) dropped 1.58 as China exposure and tech valuation concerns converged. Meanwhile, traditional energy play Vistra (VST) fell 20.93, showing that even defensive sectors couldn't hide from Friday's broad selling pressure.

🔍 5 Focus Points for Tomorrow

🏛️ Treasury yield trajectory after Friday's 11 basis point surge
🤖 Tech sector response to valuation pressure and rate concerns
🏛️ Apple's China strategy amid regulatory commission demands
📋 Healthcare sector strength following Bristol Myers FDA approval
📊 Media consolidation signals from Paramount's 6% staff cuts
Sponsored Content

Unlocked: Elon Musk's Next Big IPO

For years, the American economy has been engineered to reward Wall Street institutional investors and Silicon Valley insiders first.

Everyday investors like you and me were left with the table scraps.

But this rigged game ends today!

Click here now and Jeff Brown will show you how to claim your stake…

On what's set to be the biggest IPO in history…

Before it goes public.

💸 Bottom Line

Friday's selloff serves as a useful reminder that markets don't move in straight lines, even when the underlying economic fundamentals remain solid. The 11 basis point jump in Treasury yields provided the immediate catalyst, but the real story is whether this represents a healthy pullback or the start of something more concerning. With tech valuations stretched and geopolitical risks simmering, particularly around China, investors have legitimate reasons to reassess positioning.

The divergence between pharma's regulatory news and tech's China troubles illustrates how sector-specific catalysts can pull portfolios in different directions. Bristol Myers got a growth driver from FDA approval while Apple faces margin pressure from Beijing's regulators. These company-specific developments matter more than broad market moves when constructing a resilient portfolio.

Looking ahead, watch how tech responds to this yield-driven selloff. If the 10-year continues climbing toward 4.50%, the Nasdaq could face additional pressure as investors recalibrate growth stock valuations. On the flip side, any moderation in rates could bring buyers back quickly, especially if they view Friday's drop as an attractive entry point. The weekend will give portfolio managers time to digest the week's action and reassess whether this is a dip worth buying or a signal to raise cash.

Are you bullish or bearish on tomorrow's market?

📈 BULLISH 📉 BEARISH